tiprankstipranks
Advertisement
Advertisement
Spruce Biosciences appoints Jessica Cohen Pfeffer as VP, clinical development
PremiumThe FlySpruce Biosciences appoints Jessica Cohen Pfeffer as VP, clinical development
22d ago
Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus
Premium
Company Announcements
Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus
26d ago
Spruce Biosciences Names Adrian Quartel Chief Medical Officer
Premium
Company Announcements
Spruce Biosciences Names Adrian Quartel Chief Medical Officer
29d ago
Spruce Biosciences appoints Agnieszka Jurecka as VP, medical affairs
PremiumThe FlySpruce Biosciences appoints Agnieszka Jurecka as VP, medical affairs
2M ago
Spruce Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Spruce Biosciences initiated with a Buy at Guggenheim
2M ago
Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance
Premium
The Fly
Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance
2M ago
Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay
PremiumCompany AnnouncementsSpruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay
3M ago
Spruce Biosciences price target lowered to $150 from $170 at Citizens
Premium
The Fly
Spruce Biosciences price target lowered to $150 from $170 at Citizens
3M ago
Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11)
Premium
The Fly
Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100